Marksans Pharma Limited (MARKSANS)
ISIN: INE750C01026 Industry: Drug Manufacturers—General Sector: Healthcare Website
49.35
-0.55(-1.1%)

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

50.1

TODAY'S LOW

49.2

52 WEEK HIGH

78

52 WEEK LOW

38.6

Major Holders

% of Shares Held by
All Insider

49.98%

% of Shares Held by
Institutions

2.73%

% of Float Held by
Institutions

5.47%

Number of Institutions
Holding Shares

11

Company Overview

MARKET CAP

1993.04 Cr.

ETERPRISE VALUE

1824.25 Cr.

NO. OF SHARES

40.38 Cr.

BOOK VALUE

29.373

DIV. YIELD

0.25%

DEBT

110.77 Cr.

GROSS PROFIT

761.29 Cr.

CASH

349.69 Cr.

REVENUE

1575.64 Cr.

REVENUE/SHARE

38.508

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-15 Lakhs-15 Lakhs-15 Lakhs-15 Lakhs
Change To Liabilities18.49 Cr.47.62 Cr.66.57 Cr.9.03 Cr.
Total cashflows from Investing Activities-41.68 Cr.-44.89 Cr.-59.58 Cr.-13.47 Cr.
Net Borrowings7.03 Cr.-3.20 Cr.-70.30 Cr.-6.67 Cr.
Total Cash from Financing Activities79.51 Cr.-15.28 Cr.-113.55 Cr.-20.77 Cr.
Other Liabilities-7.40 Cr.7.13 Cr.7.89 Cr.-16.01 Cr.
Total Assets0000
Net Income186.81 Cr.238.53 Cr.120.75 Cr.80.43 Cr.
Change in Cash137.08 Cr.118.55 Cr.60.18 Cr.-6.86 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities99.25 Cr.178.74 Cr.233.32 Cr.27.39 Cr.
Depreciation44.77 Cr.30.76 Cr.21.57 Cr.19.35 Cr.
Other Cashflows from Investing Activities4.76 Cr.1 Cr.4.26 Lakhs-33.30 Lakhs
Dividends Paid-10.58 Cr.-4.09 Cr.-29.50 Cr.-4.44 Cr.
Change to Inventory-17.84 Cr.-162.47 Cr.51.40 Cr.-75.12 Cr.
Change to Account Receivables-103.93 Cr.-42.31 Cr.-66.75 Cr.30.86 Lakhs
Other Cashflows from Financing Activities83.05 Cr.-7.98 Cr.-8.74 Cr.-9.65 Cr.
Change to Net Income-21.63 Cr.58.86 Cr.31.29 Cr.8.90 Cr.
Capital Expenditures-46.33 Cr.-46.42 Cr.-59.90 Cr.-13.14 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax247.51 Cr.302.16 Cr.157.17 Cr.104.30 Cr.
Minority Interest20.70 Cr.18.85 Cr.13.11 Cr.10.21 Cr.
Net Income255.95 Cr.313.09 Cr.170.23 Cr.112.29 Cr.
Selling General Administrative220.30 Cr.209.63 Cr.178.54 Cr.165.88 Cr.
Gross Profit815.87 Cr.774.50 Cr.558.23 Cr.491.89 Cr.
Ebit255.95 Cr.313.09 Cr.170.23 Cr.112.29 Cr.
Operating Income255.95 Cr.313.09 Cr.170.23 Cr.112.29 Cr.
Other Operating Expenses294.84 Cr.220.41 Cr.187.28 Cr.193.87 Cr.
Interest Expense-8.44 Cr.-3.81 Cr.-5.81 Cr.-6.62 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense60.69 Cr.63.62 Cr.36.41 Cr.23.86 Cr.
Total Revenue1532.69 Cr.1380.05 Cr.1134.35 Cr.1000.06 Cr.
Total Operating Expenses1276.73 Cr.1066.96 Cr.964.12 Cr.887.77 Cr.
Cost of Revenue716.81 Cr.605.55 Cr.576.12 Cr.508.16 Cr.
Total Other Income Expense Net-8.44 Cr.-10.92 Cr.-13.06 Cr.-7.98 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.186.81 Cr.238.53 Cr.120.75 Cr.80.43 Cr.
Net Income Applicable to Common Shares186.81 Cr.238.53 Cr.120.75 Cr.80.43 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets58.56 Cr.47.43 Cr.48.32 Cr.40.19 Cr.
Capital Surplus0175.13 Cr.175.13 Cr.175.13 Cr.
Total Liabilities417.12 Cr.322.89 Cr.253.54 Cr.251 Cr.
Stock Holder Equity1202.27 Cr.886.49 Cr.636.01 Cr.542.48 Cr.
Minority Interest20.70 Cr.18.85 Cr.13.11 Cr.10.21 Cr.
Other Liabilities86.79 Cr.95.13 Cr.88.50 Cr.18.57 Cr.
Total Assets1640.10 Cr.1228.25 Cr.902.66 Cr.803.70 Cr.
Common Stock40.93 Cr.40.93 Cr.40.93 Cr.40.93 Cr.
Retained Earnings0648.66 Cr.398.84 Cr.316.71 Cr.
Other Liabilities19.47 Cr.10.17 Cr.12.26 Cr.8.38 Cr.
Good Will30.02 Cr.19.58 Cr.24.37 Cr.31.44 Cr.
Treasury Stock1161.33 Cr.21.76 Cr.21.10 Cr.9.70 Cr.
Other Assets8.01 Cr.4.95 Cr.6.36 Cr.2.54 Cr.
Cash349.26 Cr.212.28 Cr.93.72 Cr.33.53 Cr.
Current Liabilities356.21 Cr.298.39 Cr.228.75 Cr.232.62 Cr.
Long Term Asset Charges3.85 Cr.79.85 Lakhs63.41 Lakhs1.24 Cr.
Short Long Term Debt004.58 Lakhs30.78 Lakhs
Other Stockholder Equity1161.33 Cr.21.76 Cr.21.10 Cr.9.70 Cr.
Property Plant Equipment342.28 Cr.254.02 Cr.230.01 Cr.198.08 Cr.
Total Cur. Assets1201.20 Cr.902.25 Cr.593.58 Cr.531.44 Cr.
Long Term Investments0000
Net Tangible Assets1113.67 Cr.819.47 Cr.563.31 Cr.470.83 Cr.
Short Term Investments43.50 Lakhs000
Net Receivables397.83 Cr.271.38 Cr.243.35 Cr.183.61 Cr.
Long Term Debt05 Cr.5 Cr.10 Cr.
Inventory424.44 Cr.404.31 Cr.241.84 Cr.293.24 Cr.
Accounts Payable200.07 Cr.168.66 Cr.110.32 Cr.106.06 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account